There are also findings in humans suggesting that this T-cell population plays a relevant role in tumor regression, as clinical efficacy has been reported after passive transfer of CD4+ T cells specific for NY-ESO-1 isolated from a melanoma tumor site [29]. Here, CD4 is linked to neoplasm.